Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,204,333
-
Share change
-
-106,835
-
Total reported value
-
$1,475,380,731
-
Put/Call ratio
-
302%
-
Price per share
-
$81.00
-
Number of holders
-
83
-
Value change
-
-$6,542,188
-
Number of buys
-
41
-
Number of sells
-
39
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q1 2018
As of 31 Mar 2018,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,204,333 shares.
The largest 10 holders included
Capital Research Global Investors, BAILLIE GIFFORD & CO, Temasek Holdings (Private) Ltd, BlackRock Inc., VONTOBEL ASSET MANAGEMENT INC, VANGUARD GROUP INC, HSBC HOLDINGS PLC, COMGEST GLOBAL INVESTORS S.A.S., CREDIT SUISSE AG/, and GOLDMAN SACHS GROUP INC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.